ConvaTec Group logo

ConvaTec Group

CNVVF | OTC
Chart Builder DCF Calculator
$3.21
$0.00 (-0.16%)
At close: Oct 28, 2026, 12:33 PM ET
$3.21
$0.00 (+0.16%)
After-hours: Oct 30, 2026, 5:00 PM ET

Company Profile

ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized dressings and skincare solutions for treating both acute and chronic wounds, which can arise from conditions like diabetes, prolonged immobility, venous disease, traumatic injuries, burns, or surgical interventions. Ostomy Care: The company provides vital devices, accessories, and support services for individuals who have undergone ostomy procedures, often necessitated by conditions such as colorectal or bladder cancer, inflammatory bowel disease, or obesity. Continence and Critical Care: This division offers intermittent urinary catheters and related products to help manage urinary continence issues for patients with spinal cord injuries, multiple sclerosis, spina bifida, and other urological conditions. It also supplies a range of devices crucial for intensive care units and broader hospital settings. Specialized Monitoring and Management Systems: ConvaTec develops advanced systems for managing acute fecal incontinence, meticulously monitoring urine output, and assessing intra-abdominal pressure. Disposable Medical Supplies: Their portfolio includes a variety of single-use medical items such as wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen therapy, suction apparatus, gastroenterology tubes, and securement devices. Infusion Technology: They also manufacture disposable infusion sets for insulin pumps used in diabetes care, as well as for other continuous infusion treatments. ConvaTec distributes its products globally to a diverse clientele, including pharmacies, hospitals, and various acute and post-acute healthcare providers, either directly or via a network of distributors and wholesalers. Their customer base encompasses healthcare professionals, patients, and other manufacturers. Founded in 1978, ConvaTec Group Plc is headquartered in Reading, United Kingdom.

Key Executives

Name Position
Jonathan Mason Chief Executive Officer & Director
Anne Belcher President & Chief Operating Officer of Global Emerging Markets
Bruno Pinheiro President & Chief Operating Officer of Ostomy Care
Emma Rose EVP & Chief People Officer
Fiona Victoria Ryder Chief Financial Officer & Director
Kjersti Grimsrud Biotechnology President & Chief Operating Officer of Infusion Care
Dave Ubachs Chief Digital & Information Officer
David Shepherd Chief Commercial Officer
Evelyn Douglas EVP and Chief Strategy & Business Development Officer
James Edward Spencer Kerton EVP, General Counsel & Company Secretary
Peter Jarvis Chief Operations Officer
ConvaTec Group
ConvaTec Group logo
Country United Kingdom
IPO Date Mar 7, 2017
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 10,910
CEO Jonathan Peter Mason

Contact Details

20 Eastbourne Terrace London, GL W2 6LG United Kingdom

Stock Details

Ticker Symbol CNVVF
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number GB00BD3VFW73
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.